Dear colleagues,
Recently saw an elderly patient with severe COPD, with bilateral lung lesions, most consistent with 2 site early stage NSCLC. Both lesions were very close to the chest wall, and I recommended 2 site SBRTs, each site getting 5 fractions QOD. I did 2 iso plans to achieve the best conformality, improve cardiac sparing and limit low dose bath to the lungs between the lesions. To account for the limitation of our machine time and patient's comfort per tx session, I decided to treat her on alternating days, so that she is done in 2 wks total.
Evicore denied 2 site SBRT - because it is more than 5 fractions, they approved for 10 fraction IMRT plans.
I had a peer to peer with an agent, asked what's the rationale to call 2 site SBRT plans to a non-SBRT IMRT plan. The agent said it is purely based on the fact that it is more than 5 fractions - this is not based on per treatment target, but per 'episode'; apparently, even if I decided to treat her second target after completing the first target, they weren't going to approve 2 site SBRTs because it is under the same 'episode' and would have approved for 10 fraction IMRT. An example the agent provided for them to approve another SBRT is if the patient came a year after for the treatment.
I asked how does this logically, and technically makes sense, and he quote our very ASTRO SBRT reimbursement guideline - that anything beyond 5 fraction is not SBRT and will not reimburse as such. Many of you will agree with me that this is simply not true. Also, if they are insisting about the 5 fraction aspect of the treatment, this should be per treatment target, not per 'episode' or whatever they call it. Unfortunately, I did not have this ASTRO reimbursement guideline when I was talking to the agent (I quickly searched for the guideline while chatting with him, and found out it wasn't free...more like a $1000...and could not load it up). Regardless, they werent going to approve 2 site SBRTs no matter what. I found out later that my partner had the same issue before.
I am furious about how evicore and potentially other insurance companies are twisting the words and meaning of SBRT to undermine our (not just myself, but my dosimetrists, physicists, therapists) time and resource we put into creating high quality plans for our patients. The '10 fraction IMRT' that evicore insisted will not be acceptable for my patient, and I am delivering the 2 SBRT plans regardless (and still charging the 10 fraction IMRT). However, it is absolutely wrong for evicore to take advantage of us this way (or alternatively, give suboptimal care with non-SBRTs). I am also concerned about the future implication of the 5 fraction definition for the SBRT per the ASTRO guideline - how can we appropriately charge multiple site SBRTs in the era of oligometastatic treatment paradigm? Let's say we are treating a spine and a liver lesion for >5 treatments (2-5 fraction for spine, 3-5 fractions for liver; examples for more challenging SBRTs) under the same 'episode' -should we be charged for non SBRT IMRT for this?
What are your thoughts on this matter? Anyone in ASTRO have looked into this?
Recently saw an elderly patient with severe COPD, with bilateral lung lesions, most consistent with 2 site early stage NSCLC. Both lesions were very close to the chest wall, and I recommended 2 site SBRTs, each site getting 5 fractions QOD. I did 2 iso plans to achieve the best conformality, improve cardiac sparing and limit low dose bath to the lungs between the lesions. To account for the limitation of our machine time and patient's comfort per tx session, I decided to treat her on alternating days, so that she is done in 2 wks total.
Evicore denied 2 site SBRT - because it is more than 5 fractions, they approved for 10 fraction IMRT plans.
I had a peer to peer with an agent, asked what's the rationale to call 2 site SBRT plans to a non-SBRT IMRT plan. The agent said it is purely based on the fact that it is more than 5 fractions - this is not based on per treatment target, but per 'episode'; apparently, even if I decided to treat her second target after completing the first target, they weren't going to approve 2 site SBRTs because it is under the same 'episode' and would have approved for 10 fraction IMRT. An example the agent provided for them to approve another SBRT is if the patient came a year after for the treatment.
I asked how does this logically, and technically makes sense, and he quote our very ASTRO SBRT reimbursement guideline - that anything beyond 5 fraction is not SBRT and will not reimburse as such. Many of you will agree with me that this is simply not true. Also, if they are insisting about the 5 fraction aspect of the treatment, this should be per treatment target, not per 'episode' or whatever they call it. Unfortunately, I did not have this ASTRO reimbursement guideline when I was talking to the agent (I quickly searched for the guideline while chatting with him, and found out it wasn't free...more like a $1000...and could not load it up). Regardless, they werent going to approve 2 site SBRTs no matter what. I found out later that my partner had the same issue before.
I am furious about how evicore and potentially other insurance companies are twisting the words and meaning of SBRT to undermine our (not just myself, but my dosimetrists, physicists, therapists) time and resource we put into creating high quality plans for our patients. The '10 fraction IMRT' that evicore insisted will not be acceptable for my patient, and I am delivering the 2 SBRT plans regardless (and still charging the 10 fraction IMRT). However, it is absolutely wrong for evicore to take advantage of us this way (or alternatively, give suboptimal care with non-SBRTs). I am also concerned about the future implication of the 5 fraction definition for the SBRT per the ASTRO guideline - how can we appropriately charge multiple site SBRTs in the era of oligometastatic treatment paradigm? Let's say we are treating a spine and a liver lesion for >5 treatments (2-5 fraction for spine, 3-5 fractions for liver; examples for more challenging SBRTs) under the same 'episode' -should we be charged for non SBRT IMRT for this?
What are your thoughts on this matter? Anyone in ASTRO have looked into this?